Kamran Alam - 04 Feb 2026 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Kamran Alam
Issuer symbol
TSHA
Transactions as of
04 Feb 2026
Net transactions value
-$7,481
Form type
4
Filing time
06 Feb 2026, 16:30:29 UTC
Previous filing
27 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Alam Kamran CHIEF FINANCIAL OFFICER C/O TAYSHA GENE THERAPIES, INC., 3000 PEGASUS PARK DRIVE, STE 1430, DALLAS /s/ Kamran Alam 06 Feb 2026 0001793412

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSHA Common Stock Sale $7,481 -1,655 -0.11% $4.52 1,442,131 04 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only.